Barclays’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Barclays’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-46	Closed	-$45	–	5684
2024 Q4	$45	Buy	46 +19	+70%	+$61	﹤0.01%	5202
2024 Q3	$92	Buy	+27	New	+$152	﹤0.01%	5184
2021 Q1	–	Sell	-3	Closed	-$1K	–	5295
2020 Q4	$1K	Buy	+3	New	+$1.25K	﹤0.01%	4835
2020 Q3	–	Hold	0	–	–	–	5668
2020 Q2	–	Hold	0	–	–	–	6372

Barclays's VCNX Position: Q1 2025 in Review

Barclays sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2025, closing a stake of 46 shares — an estimated $45 sold.

Barclays first reported a position in VCNX in Q4 2020 and held it in 3 quarters. The position peaked at $1K in Q4 2020. 0 funds tracked by Wall St. Rank hold VCNX as of Q1 2025.

Barclays reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Barclays sold 46 Vaccinex, Inc. Common Stock shares in Q1 2025, an estimated $45.
Barclays first reported a position in Vaccinex, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
Barclays's Vaccinex, Inc. Common Stock position peaked at $1K in Q4 2020.
0 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.